NCT00922779View on ClinicalTrials.gov

A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic Hepatitis C

PHASE4CompletedINTERVENTIONAL
Enrollment

6,661

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Hepatitis C, Chronic
Interventions
DRUG

peginterferon alfa-2a [Pegasys]

180micrograms sc weekly for 12-48 weeks

DRUG

ribavirin

800mg, or 1000-1200mg, po daily (dependent on HCV genotype and body weight)

Trial Locations (93)

103875

Moscow

105203

Moscow

109325

Moscow

111020

Moscow

111123

Moscow

115201

Moscow

115446

Moscow

115516

Moscow

115682

Moscow

119002

Moscow

119881

Moscow

121293

Moscow

123098

Moscow

123367

Moscow

125101

Moscow

125367

Moscow

127247

Moscow

129110

Moscow

143420

Moscow

162600

Cherepovets

163000

Arkhangelsk

191167

Saint Petersburg

194044

Saint Petersburg

194291

Saint Petersburg

195067

Saint Petersburg

195275

Saint Petersburg

197022

Saint Petersburg

198103

Saint Petersburg

199034

Saint Petersburg

344022

Rostov-on-Don

350012

Krasnodar

350015

Krasnodar

350086

Krasnodar

354057

Sashi

355017

Stavropol

367008

Makhachkala

398043

Lipetsk

400040

Volgograd

400138

Volgograd

410026

Saratov

410028

Saratov

410040

Saratov

420097

Kazan'

426067

Izhevsk

428016

Cheboksary

443011

Samara

443021

Samara

450000

Ufa

450005

Ufa

454048

Chelyabinsk

454052

Chelyabinsk

454071

Chelyabinsk

460035

Orenburg

603022

Nizhny Novgorod

610000

Kirov

620020

Yekaterinburg

620042

Yekaterinburg

620102

Yekaterinburg

624130

Novoural'sk

625002

Tyumen

625017

Tyumen

625026

Tyumen

628400

Surgut

629001

Salekhard

629806

Tyumen

630016

Novosibirsk

634050

Tomsk

644010

Omsk

650000

Kemerovo

650036

Kemerovo

650099

Kemerovo

654018

Novokuznetsk

654029

Novokuznetsk

656010

Barnaul

656045

Barnaul

660022

Krasnoyarsk

660049

Krasnoyarsk

664043

Irkutsk

664047

Irkutsk

664079

Irkutsk

670042

Ulan-Ude

672090

Chita

675007

Blagoveshchensk

677000

Yakutsk

680009

Khabarovsk

680022

Khabarovsk

680031

Khabarovsk

683003

Petropavlovsk-Kamchatskiy

690000

Yujno-sakhalinsk

690011

Vladivostok

690065

Vladivostok

693000

Yujno-sakhalinsk

Unknown

Moscow

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00922779 - A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic Hepatitis C | Biotech Hunter | Biotech Hunter